Untersuchungen zur Spezifität der drei Screening-Parameter HBsAg, Anti-HIV-1/HIV-2 und Anti-HCV mit dem neuen ABBOTT PRISM®-System im Vergleich zum ABBOTT COMMANDER®-System

Publisher： Karger

E-ISSN： 1660-3818|26|1|38-44

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.26, Iss.1, 1999-02, pp. : 38-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validation of the Serological Testing for Anti-HIV-1/2, Anti-HCV, HBsAg, and Anti-HBc from Post-mortem Blood on the Siemens-BEP-III Automatic System

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 6, 2011-11 ,pp. : 365-372

Karger

Access to resources Recommend Favorite

Head‐to‐head comparison between two screening systems for HBsAG, anti‐HBc, anti‐HCV and HIV combination immunoassays in an international, multicentre evaluation study

By  

VOX SANGUINIS, Vol. 109, Iss. 2, 2015-08 ,pp. : 114-121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synthesis, biological screening and ADME prediction of benzylindole derivatives as novel anti-HIV-1, anti-fungal and anti-bacterial agents

By Kashid A.   Dube P.   Alkutkar P.   Bothara K.   Mokale S.   Dhawale S.  

Medicinal Chemistry Research, Vol. 22, Iss. 10, 2013-10 ,pp. : 4633-4640

Springer Publishing Company

Access to resources Recommend Favorite

Validation of a PCR Assay System to Screen Plasma for HBV, HCV, and HIV-1

By  

Transfusion Medicine and Hemotherapy, Vol. 25, Iss. 2-3, 1998-06 ,pp. : 139-146

Karger

Access to resources Recommend Favorite

QSAR study on some arylsulfonamides as anti-HIV agents

By Ravichandran Veerasamy  

Medicinal Chemistry Research, Vol. 16, Iss. 7-9, 2007-12 ,pp. : 342-351

Springer Publishing Company

Access to resources Recommend Favorite